Julie Filipenko

3.1k total citations
7 papers, 68 citations indexed

About

Julie Filipenko is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Julie Filipenko has authored 7 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Julie Filipenko's work include Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Julie Filipenko is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Julie Filipenko collaborates with scholars based in United States, Canada and United Kingdom. Julie Filipenko's co-authors include S. Zabele, Asmir Vodenčarević, Leslie S. Prichep, A. Jacquin, Howard I. Scher, Nicholas Bruchovsky, Michael J. Morris, Paul S. Rennie, Neal D. Shore and Fred Saad and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical Journal.

In The Last Decade

Julie Filipenko

7 papers receiving 63 citations

Peers

Julie Filipenko

EPIDE

NEURO

EM

PRM

CN

Jerónimo Moreno-Cuesta United Kingdom

Jakub Soršák Slovakia

Hugues Blangy France

L Libero Italy

Perrine Boursin France

Shihong Zhang China

H. Dupont France

Jenny Gurney United States

Ibrahim Mohammadzadeh Iran

Annaelle Zietz Switzerland

Jerónimo Moreno-Cuesta United Kingdom

Julie Filipenko

24 ×0.9

EPIDE

26 ×1.2

NEURO

14 ×0.6

EM

8 ×0.4

PRM

1 ×0.1

CN

Citations per year, relative to Julie Filipenko Julie Filipenko (= 1×) peers Jerónimo Moreno-Cuesta

Countries citing papers authored by Julie Filipenko

Since Specialization

Citations

This map shows the geographic impact of Julie Filipenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Filipenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Filipenko more than expected).

Fields of papers citing papers by Julie Filipenko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Filipenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Filipenko. The network helps show where Julie Filipenko may publish in the future.

Co-authorship network of co-authors of Julie Filipenko

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Filipenko. A scholar is included among the top collaborators of Julie Filipenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Filipenko. Julie Filipenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Morris, Michael J., José Maurício Mota, Patrick Hilden, et al.. (2021). Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503). European Urology Oncology. 4(4). 543–552. 11 indexed citations

2.

Danila, Daniel C., Timothy M. Kuzel, Jeremy Cetnar, et al.. (2016). A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naïve patients with progressive metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 34(15_suppl). e16507–e16507. 2 indexed citations

3.

Nelson, Peter S., Joaquı́n Mateo, Himisha Beltran, et al.. (2016). Inherited mutations in DNA repair genes in men with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 34(15_suppl). 5009–5009. 3 indexed citations

4.

Morris, Michael J., Patrick Hilden, Martin Gleave, et al.. (2015). Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy.. Journal of Clinical Oncology. 33(15_suppl). 5011–5011. 6 indexed citations

5.

Prichep, Leslie S., et al.. (2012). Classification of Traumatic Brain Injury Severity Using Informed Data Reduction in a Series of Binary Classifier Algorithms. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 20(6). 806–822. 40 indexed citations

6.

Filipenko, Julie, Linda M. Vickars, Paul F. Galbraith, et al.. (2005). BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.. Blood. 106(11). 4674–4674. 1 indexed citations

7.

Filipenko, Julie, Paul S. Rennie, & Nicholas Bruchovsky. (1981). The androgenic regulation of superhelical-DNA nicking-closing enzyme in rat ventral prostate. Biochemical Journal. 196(1). 195–202. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact